Searchable abstracts of presentations at key conferences in endocrinology

ea0020p656 | Reproduction | ECE2009

Use of estradiol benzoate in presynch method in lactating dairy cows

Laleh Vahid Ghaffari , Asadi Ali , Mohammadi Mohammad Tagi

The aim of this study was to determine of pregnancy rate when Estradiol Benzoate (EB) used in presynch method than to routine presynchronization protocol in lactating dairy cows (N: 210). In this study, cows divided in two treatment groups: control group (N: 100) and main group (N: 110). Control group cows received two injections of Cloprostenol (750 μg/Case, IM) with 14 d interval. Then, they received an injection of Gonadorelin (100 μg/Case, IM...

ea0019p341 | Thyroid | SFEBES2009

Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

Mirpour Sahar , Gholamrezanezhad Ali , Saghari Mohsen , Beiki Davood

Introduction: In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result – increased thyroglobulin with negative WBS – is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results.Method: We studied 32 differentiated thyroid carcinoma patients with...

ea0018p34 | (1) | MES2008

A potential complication of radiotherapy for acromegaly

Lecamwasam Varunika , Abbara Ali , Bell Richard , Baynes Kevin , Rafique Akkib

Case report: A 40-year-old lady was diagnosed with acromegaly in 1993 after presentation with clinical symptoms. Imaging showed a 1 cm pituitary lesion and she underwent transphenoidal hypophysectomy in 1993. Post-operatively she was rendered hypopituitary, but still had biochemical evidence of active acromegaly. She proceeded to external beam radiotherapy and was started on bromocriptine medical therapy.On routine review in 2006, her acromegaly was bioc...

ea0017p32 | (1) | BSPED2008

TRIAC and carbimazole combination therapy in pituitary thyroid hormone resistance

Ali K , Culley V , Morovat R , Ryan F , Edge J

We present a difficult case of pituitary thyroid hormone resistance (PTHR) in a 6 year old girl. She presented at the age of 22 months with chronic cough, diarrhoea, failure to gain weight and gross motor delay. She was also noted to be hyperactive and clumsy with poor co-ordination. Persistent tachycardia was present on examination. Thyroid function tests revealed increased thyroid hormone concentrations with a free T4 of 63.7 pmol/l (9–25) and a free T3 of 20 pmol/l (3....

ea0016p501 | Obesity | ECE2008

Overweight adolescents, a group at risk for metabolic syndrome (Tehran Adolescent Obesity Study)

Moayeri Heshmat , Bidad Katayoon , Rabbani Ali , Keihani doust Zarrin

Background: Metabolic syndrome not only is a serious problem for adults, but is also afflicting an increasing number of children and adolescents. This syndrome is a risk factor for type 2 diabetes mellitus and cardiovascular diseases. The aim of this study was to estimate the prevalence of metabolic syndrome in a sample of Iranian adolescents.Methods: A total of 554 overweight adolescents (aged 11–17 years) participated in a community-based cross se...

ea0014p250 | (1) | ECE2007

Relationship between obesity, insulin resistance and adipokines in morbidly obese women

Madani Rana , Miheisi Nazar , Hashemi Majid , Mohamed-Ali Vidya

Background: Several cytokines and chemokines are released by adipose tissue and associated with insulin resistance. We investigated the systemic and in vitro release of RANTES(Regulated upon Activation Normal T-cell Expressed and Secreted), MCP-1(Monocyte Chemo-attractant Protein-1), adiponectin, leptin and IL-6 from three human adipose tissue depots and their relationship to insulin sensitivity.Methods: Fasting blood samples were taken from obese...

ea0011p20 | Bone | ECE2006

Treatment and follow up of primary hyperparathyroidism: 50 cases

Cheikhrouhou Hela , Ali Insaf Hadj , Khiari Karima , Abdallah Nejib Ben

We report a retrospective study of 50 cases of primary hyperparathyroidism (10 men and 40 women, mean age: 49 years) collected between 1975 and 2004. At the time of diagnosis, 44% of patients had bone disease, renal manifestations were present in 17 cases (34%).Parathyroidectomy is a safe and effective approach of primary hyperparathyroidism treatment. The management of persistent or recurrent hyperparathyroidism is explained by the fact that parathyroid...

ea0011p318 | Diabetes, metabolism and cardiovascular | ECE2006

Cardiovascular risk factors and macrovascular complications in type 2 diabetes

Khiari Karima , Cheikhrouhou Hela , Ali Insaf Hadj , Abdallah Nejib Ben

The frequency of type 2 diabetes increases in all of the world. The risk for atherosclerosis vascular disease is greatest in type 2 diabetic patients who have other known risk factors such obesity, smoking, hypertension and dyslipidemia.The aim of our study is to determine the frequency of cardiovascular risk factors associated to diabetes and the frequency of macrovascular complications in type 2 diabetic patients.It is a retrospe...

ea0011p481 | Endocrine tumours and neoplasia | ECE2006

Macroprolactinoma: 5 cases

Hadj Ali Insaf , Cheikhrouhou Hela , Khiari Karima , Ben Abdallah Nejib

Prolactinoma represents 27 to 35% of pituitary adenomomas and 40 to 75% of secreting adenomas. However, the macroprolactinomas are not frequent. We report clinical, biological and therapeutic aspects of 5 cases of macroprolactinomas. It concerns 3 women and 2 men. The average age is 43.4 years (19–68). The reason for seaking medical advice was amenorrhea – galactorrhea syndrom in 2 women and infertility in one case. The diagnosis of pituitary adenoma is incidentally ...

ea0011p835 | Thyroid | ECE2006

On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma

Gholamrezanezhad Ali , Saghari Mohsen , Mirpour Sahar , Beiki Davoud

At the present time, the most widely accepted tool for follow-up management of differentiated thyroid cancer (DTC) patients consists of serum thyroglobulin (Tg) measurement. It is not uncommon to measure the serum Tg level while the patient taking thyroid hormones (on-treatment Tg measurement). The purpose of the study was to evaluate the accuracy of on-treatment measurement of serum Tg in detecting remnant/recurrent or metastatic disease in high risk DTC patients. Patients an...